GermanyA new study suggests that the Epstein-Barr virus may play a role in triggering multiple sclerosis (MS), an autoimmune disease. Researchers have found evidence pointing to overactive immune cells in MS patients, offering hope for new treatments. According to neuroimmunologist Klemens Ruprecht, nearly all MS patients had previously been infected with the Epstein-Barr virus, as shown by a large U.S. study from 2022. A follow-up study published in Science Translational Medicine by researchers at Harvard University examined how parts of the immune system react to the Epstein-Barr virus in MS patients. The study focused on T-helper cells, which direct the immune system, and found that the immune response in MS patients is significantly stronger compared to healthy individuals. While most people infected with the Epstein-Barr virus do not develop MS, the research indicates that something beyond the infection itself differentiates those who do.
Bias read (Center): The article discusses medical research findings related to the Epstein-Barr virus and its potential connection to multiple sclerosis. It presents scientific data and expert opinions without overtly favoring any particular viewpoint or ideology. There is no indication of political framing or bias in措
